v3.26.1
Segment Reporting
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting

10. Segment Reporting

The following table provides the operating financial results of the Company’s single reportable segment. It includes the significant expense categories regularly provided to the Company’s "chief operating decision maker", its Chief Executive Officer, computed under GAAP and reconciled to the Company’s total “net loss” as presented in the Condensed Statements of Operations and Comprehensive Loss:

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

(in thousands)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenue

 

$

18,940

 

 

$

12,083

 

 

$

35,056

 

 

$

22,272

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

4,398

 

 

 

3,214

 

 

 

8,089

 

 

 

5,767

 

Selling expenses

 

 

9,157

 

 

 

6,028

 

 

 

17,042

 

 

 

11,042

 

Marketing expenses

 

 

1,173

 

 

 

840

 

 

 

2,663

 

 

 

1,772

 

Product and software development costs

 

 

3,576

 

 

 

2,171

 

 

 

6,652

 

 

 

3,651

 

Clinical, medical, and regulatory expenses

 

 

1,358

 

 

 

1,167

 

 

 

2,705

 

 

 

2,188

 

Other segment expenses*

 

 

10,314

 

 

 

5,165

 

 

 

18,217

 

 

 

10,073

 

Interest expense

 

 

313

 

 

 

363

 

 

 

624

 

 

 

720

 

Interest income

 

 

(839

)

 

 

(336

)

 

 

(1,730

)

 

 

(716

)

Change in fair value of warrant liabilities

 

 

—

 

 

 

237

 

 

 

—

 

 

 

270

 

Net loss

 

$

(10,510

)

 

$

(6,766

)

 

$

(19,206

)

 

$

(12,495

)

 

* Other segment expenses primarily include corporate, compliance, and research and development support expenses.